Anemia News, Research Articles | Anemia Treatment Studies

Anemia

ANEMIA

man-injection-0316

Cardiovascular Risks Similar for Monthly, Short-Acting ESAs

Over a median 5.1 years, similar proportions of patients who received monthly methoxy polyethylene glycol epoetin beta arm and a reference group treated with conventional ESAs experienced major cardiovascular events and death.
Next post in Anemia